Motley Fool Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History
Motley Fool Asset Management LLC
- $1.85 Billion
- Q4 2024
A detailed history of Motley Fool Asset Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Motley Fool Asset Management LLC holds 1,899 shares of ALNY stock, worth $486,998. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,899
Previous 1,760
7.9%
Holding current value
$486,998
Previous $484,000
7.85%
% of portfolio
0.02%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding ALNY
# of Institutions
673Shares Held
112MCall Options Held
943KPut Options Held
922K-
Capital World Investors Los Angeles, CA16.6MShares$4.26 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.27 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.45 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.79 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.12 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...